News
Filter
-
MRC Technology enters into an exclusive license agreement with Genentech
Read more: MRC Technology enters into an exclusive license agreement with Genentech -
“Skills Swap” to exploit expertise for patient benefit
Read more: “Skills Swap” to exploit expertise for patient benefit -
AstraZeneca and MRC Technology form strategic alliance in discovery research, utilising shared compound libraries
Read more: AstraZeneca and MRC Technology form strategic alliance in discovery research, utilising shared compound libraries -
Adding value to early stage IP
Read more: Adding value to early stage IP -
O2h provides multi-FTE -synthetic chemistry services to MRCT
Read more: O2h provides multi-FTE -synthetic chemistry services to MRCT -
MRCT’s call for targets
Read more: MRCT’s call for targets -
Collaboration between Georg-August-University Göttingen, Universitätsmedizin, the University of Regensburg and MRCT
Read more: Collaboration between Georg-August-University Göttingen, Universitätsmedizin, the University of Regensburg and MRCT -
DiscoveRX, GSK & MRCT collaborate to de-orphanise GPCRs
Read more: DiscoveRX, GSK & MRCT collaborate to de-orphanise GPCRs -
Bicycle Therapeutics is new MRC spinout
Read more: Bicycle Therapeutics is new MRC spinout -
DiscoveRX GSK and MRCT collaborate to deorphanise GPCRs
Read more: DiscoveRX GSK and MRCT collaborate to deorphanise GPCRs -
Centre for Therapeutics Discovery
Read more: Centre for Therapeutics Discovery -
Heptares secures funding
Read more: Heptares secures funding